LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a number one world medical expertise firm, right now introduced the presentation of latest knowledge supporting the usage of Orthofix (NASDAQ:)’s proprietary Pulsed Electromagnetic Area (PEMF) stimulation to extend fusion charges as an adjunct to lumbar backbone fusion surgical procedure. Sufferers handled with the SpinalStim™ bone development remedy system demonstrated a excessive price of profitable fusion with vital enhancements in ache, operate and high quality of life, regardless of having threat elements for pseudarthrosis.
The summary can be offered by Dr. Marc Weinstein, an orthopedic backbone surgeon on the Florida Orthopaedic Institute in Tampa, Florida, on the North American Backbone Society (NASS) Annual Assembly in Chicago, IL, on September 25, in the course of the Analysis and Innovation Showcase within the McCormick (NYSE:) Place West Foyer of the McCormick Conference Heart.
In the course of the NASS annual assembly, Orthofix can also be highlighting a wide range of new merchandise together with the complete market launch of OsteoStrand™ Plus C. A 100% bone-derived graft, OsteoStrand Plus C is comprised of Demineralized Bone Matrix (DBM) fibers and Accell™ Bone Matrix, a dispersed type of DBM that gives rapid launch of development elements upon implantation and will increase the focus of development elements within the product, and cancellous chips. Used as a bone graft materials in fusion purposes, the OsteoStrand Plus C options improved graft packability relative to non-chip containing choices “ for a denser fill and to make sure minimal graft displacement. Moreover, Orthofix is asserting the launch of the M6-C™ Single-Use, Disposable Instrumentation units, the primary FDA-cleared, single-use, disposable devices designed particularly for cervical disc arthroplasty.
Orthofix Sponsored Occasions
Orthofix can be sponsoring alternatives to be taught extra concerning the 7D FLASH™ Navigation System via an academic dinner with Dr. Jason McGowan and Dr. Amir Vokshoor. Moreover, the corporate is providing an academic dinner for surgeons to be taught extra about optimizing fusion via figuring out the fitting mixture of interbody floor expertise, data-driven biologics, and bone development therapies with Dr. Raymond Hah and Dr. James Bruffey.
These attending NASS can be taught extra about these occasions and Orthofix’s portfolio of backbone options by visiting sales space #3017.
About Orthofix
Orthofix is a world medical expertise firm headquartered in Lewisville, Texas. By offering medical applied sciences that heal musculoskeletal pathologies, we ship distinctive experiences and life-changing options to sufferers around the globe. Orthofix provides a complete portfolio of spinal {hardware}, bone development therapies, specialised orthopedic options, biologics and enabling applied sciences, together with the 7D FLASH™ Navigation System. To be taught extra, go to Orthofix.com and comply with Orthofix on LinkedIn.
Ahead-Wanting Statements
This information launch might embrace forward-looking statements inside the which means of Part 21E of the Securities Trade Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended. In some instances, you may establish forward-looking statements by terminology comparable to might, will, ought to, expects, plans, anticipates, believes, estimates, initiatives, intends, predicts, potential, proceed or different comparable terminology. Orthofix cautions you that statements included on this information launch that aren’t an outline of historic details are forward-looking statements which can be primarily based on the Firm’s present expectations and assumptions. Every forward-looking assertion contained on this information launch is topic to dangers and uncertainties that would trigger precise outcomes to vary materially from these expressed or implied by such assertion. Relevant dangers and uncertainties embrace, amongst others: the power of newly launched merchandise to carry out as designed and supposed and to fulfill the wants of surgeons and sufferers, together with because of the shortage of sturdy medical validation; and the dangers recognized below the heading Danger Components in Orthofix Medical Inc.’s Annual Report on Type 10-Ok for the fiscal yr ended December 31, 2023, which was filed with the Securities and Trade Fee (SEC) on March 5, 2024, in addition to any subsequent Quarterly Report on Type 10-Q or Present Report on Type 8-Ok filed with the SEC. The Firm’s public filings with the SEC can be found at www.sec.gov. You might be cautioned to not place undue reliance on forward-looking statements, which communicate solely as of the date when made. Orthofix doesn’t intend to revise or replace any forward-looking assertion set forth on this information launch to replicate occasions or circumstances arising after the date hereof, besides as could also be required by regulation.
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20240923211580/en/
Media Relations
Denise Landry
DeniseLandry@Orthofix.com
214.937.2529
Investor Relations
Julie Dewey
JulieDewey@Orthofix.com
209.613.6945
Supply: Orthofix Medical Inc.
